TB-500 treatment results in decreased F-actin/G-actin ratios, quantifiable through biochemical fractionation and Western blot analysis using specific actin antibodies
Then during the pandemic, and realizing this is growing, because again, we train practices in the medicine that we practice, we trained 300, 350 practices and give them playbook, so to speak, people weren't coming to the office as much with COVID, so we started doing it subcutaneously
The multi-dose capability is particularly valuable in high-volume settings where multiple patients may require the same medication
Lancet 390(10103):16641675 Athauda D, Gulyani S, Kumar Karnati H et al (2019) Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide-PD trial
Gastrointestinal Research Much of the initial work focused on the digestive tract
[2] It appears to act at the gene level to increase actin production, whereas TB-500 is an actin-binding protein that appears to sequester actin in areas where its requirement is maximum for cell movement